These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 16045305
1. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models. Gopalakrishnan B, Aparna V, Jeevan J, Ravi M, Desiraju GR. J Chem Inf Model; 2005; 45(4):1101-8. PubMed ID: 16045305 [Abstract] [Full Text] [Related]
2. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints. Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI. J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713 [Abstract] [Full Text] [Related]
3. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors. Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ. J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716 [Abstract] [Full Text] [Related]
4. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods. Aparna V, Jeevan J, Ravi M, Desiraju GR, Gopalakrishnan B. Bioorg Med Chem Lett; 2006 Feb 15; 16(4):1014-20. PubMed ID: 16290929 [Abstract] [Full Text] [Related]
9. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv. Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A. Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3053-8. PubMed ID: 17418569 [Abstract] [Full Text] [Related]
10. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase. Familiar O, Munier-Lehmann H, Negri A, Gago F, Douguet D, Rigouts L, Hernández AI, Camarasa MJ, Pérez-Pérez MJ. ChemMedChem; 2008 Jul 01; 3(7):1083-93. PubMed ID: 18418833 [Abstract] [Full Text] [Related]
11. Design of fructose-2,6-bisphosphatase inhibitors: a novel virtual screening approach. Shaikh MS, Mittal A, Bharatam PV. J Mol Graph Model; 2008 Feb 01; 26(6):900-6. PubMed ID: 17644015 [Abstract] [Full Text] [Related]
14. 3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Vanheusden V, Munier-Lehmann H, Froeyen M, Dugué L, Heyerick A, De Keukeleire D, Pochet S, Busson R, Herdewijn P, Van Calenbergh S. J Med Chem; 2003 Aug 28; 46(18):3811-21. PubMed ID: 12930144 [Abstract] [Full Text] [Related]
17. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits. Ananthula RS, Ravikumar M, Pramod AB, Madala KK, Mahmood SK. J Mol Graph Model; 2008 Nov 28; 27(4):546-57. PubMed ID: 18993099 [Abstract] [Full Text] [Related]
18. Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies. Chikhale RV, Pawar SP, Kolpe MS, Shinde OD, Dahlous KA, Mohammad S, Patil PC, Bhowmick S. Mol Divers; 2024 Aug 28; 28(4):1947-1964. PubMed ID: 39152354 [Abstract] [Full Text] [Related]
19. Design of Mycobacterium tuberculosis thymidine monophosphate kinase inhibitors. Munier-Lehmann H, Pochet S, Dugue L, Dutruel O, Labesse G, Douget D. Nucleosides Nucleotides Nucleic Acids; 2003 Aug 28; 22(5-8):801-4. PubMed ID: 14565282 [No Abstract] [Full Text] [Related]
20. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans. Pochet S, Dugué L, Labesse G, Delepierre M, Munier-Lehmann H. Chembiochem; 2003 Aug 04; 4(8):742-7. PubMed ID: 12898625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]